Suicidality clinical trials

Explore recruiting suicidality clinical trials.

Recruiting suicidality studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Suicidality trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicenter, international, open-label, safety study of ND0612, a solution of levodopa/carbidopa delivered via a pump system as a continuous subcutaneous infusion in subjects with advanced Parkinson's Disease (BeyoND)

Italy, Austria, France, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double-blind, Placebo-controlled, Phase IIb, Multi-center, Twelve-week Prospective Study to Evaluate the Efficacy and Safety of Gemlapodect in Adult and Adolescent Patients with Tourette Syndrome – Allevia 2

Spain, France, Poland, Hungary, Belgium, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD)

Sweden, Hungary, France, Portugal, Slovakia, Poland +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures

Poland, Germany, Czechia, Italy, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, placebo-controlled, parallel group, 72-week study to evaluate the efficacy and safety of VHB937 in participants with early Alzheimer’s Disease followed by an Extension

Netherlands, Germany, Italy, Poland, Spain, Czechia +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1)

Spain, Poland, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

Suicidality trials by city

Suicidality in Toronto Suicidality in Vancouver Suicidality in Montreal Suicidality in Calgary Suicidality in Edmonton Suicidality in Ottawa Suicidality in Winnipeg Suicidality in Quebec City Suicidality in Hamilton Suicidality in Kitchener Suicidality in London Suicidality in Halifax Suicidality in New York Suicidality in Los Angeles Suicidality in Chicago Suicidality in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease